Desai Veeral

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$0
Insider Sells Quantity
15
Insider Sells Sum
$51.96M

Insider Activity of Desai Veeral

The largest sale of all time was on 2022-07-07 and amounted to 638142 shares of agilon health, inc. for $15.95M.

Biography of Desai Veeral

No biography is available at this moment.

2024-03-14Purchaseagilon health, inc.
AGL
Chief Strategy & Dev. Officer
11,956
$0$0-1.15%
2023-05-09Saleagilon health, inc.
AGL
Chief Strategy & Dev. Officer
4,500
0.0011%
$26.15$117,666-49.08%
2023-04-20Saleagilon health, inc.
AGL
Chief Strategy & Dev. Officer
500
0.0001%
$26.15$13,074-32.25%
2023-04-19Saleagilon health, inc.
AGL
Chief Strategy & Dev. Officer
5,000
0.0012%
$26.91$134,544-36.41%
2023-03-24Saleagilon health, inc.
AGL
Chief Strategy & Dev. Officer
97,290
0.0236%
$28.70$2.79M-39.21%
2023-03-23Saleagilon health, inc.
AGL
Chief Strategy & Dev. Officer
22,710
0.0056%
$28.71$651,911-38.57%
2023-03-16Saleagilon health, inc.
AGL
Chief Strategy & Dev. Officer
60,000
0.0146%
$26.09$1.57M-31.92%
2022-07-21Saleagilon health, inc.
AGL
Chief Strategy & Dev. Officer
159,536
0.0389%
$27.50$4.39M-22.9%
2022-07-07Saleagilon health, inc.
AGL
Chief Strategy & Dev. Officer
638,142
0.1496%
$25.00$15.95M-15.8%
2022-06-24Saleagilon health, inc.
AGL
Chief Strategy & Dev. Officer
212,714
0.0535%
$22.50$4.79M+0.73%
2022-04-22Saleagilon health, inc.
AGL
Chief Strategy & Dev. Officer
26,789
0.007%
$20.00$535,780+12.89%
2022-04-21Saleagilon health, inc.
AGL
Chief Strategy & Dev. Officer
106,357
0.0274%
$20.40$2.17M+8.78%
2022-04-20Saleagilon health, inc.
AGL
Chief Strategy & Dev. Officer
106,357
0.0269%
$22.34$2.38M-2.35%
2022-04-19Saleagilon health, inc.
AGL
Chief Strategy & Dev. Officer
212,714
0.0516%
$22.54$4.79M-7.11%
2022-03-16Saleagilon health, inc.
AGL
Chief Strategy & Dev. Officer
394,582
0.1004%
$20.41$8.05M+6.17%
2021-09-14Saleagilon health, inc.
AGL
Chief Strategy & Dev. Officer
242,002
0.0298%
$14.99$3.63M-26.54%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.